Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Bone Marrow Transplant. 2010 Sep 6;46(6):813–819. doi: 10.1038/bmt.2010.210

Table 8.

Risk-factor analysis before allo-BMT MR study results in ON-positive (n = 23) and ON-negative (n = 84) patients

ON-positive
[n (%)]
ON-negative
[n (%)])
Odds Ratio
(95% CI)
P value
Gender
 Male 10 (14.49) 59 (85.51) 0.02
 Female 13 (34.21) 25 (65.79) 3.07 (1.19, 7.92)
Race
 Other 3 (11.11) 24 (88.89) 0.28
 Black 5 (20.83) 19 (79.17) 2.11 (0.45, 9.95)
 White 15 (26.79) 41 (73.21) 2.93 (0.77, 11.16)
BMI at MR study 1
 Normal 9 (16.07) 47 (83.93) 0.65
 Underweight 2 (33.33) 4 (66.67) 2.61 (0.41, 16.46)
 Overweight 5 (26.32) 14 (73.68) 1.87 (0.54, 6.48)
 Obese 3 (18.75) 13 (81.25) 1.21 (0.28, 5.11)
Age at MR study
 <10 3 (8.82) 31 (91.18) 0.04
 ≥10 20 (27.40) 53 (72.60) 3.90 (1.07, 14.18)
Age at Primary Diagnosis
 ≤2 2 (9.09) 20 (90.91) 0.27
 2 – 10 8 (21.62) 29 (78.38) 2.76 (0.53, 14.37)
 ≥10 13 (27.08) 35 (72.92) 3.71 (0.76, 18.15)
Primary Diagnosis
 Others 10 (16.13) 52 (83.87) 0.12
 Lymphoid Malignancy &
Aplastic Anemia
13 (28.89) 32 (71.11) 2.11 (0.83, 5.38)
Multivariable analysis
Variable Odds ratio (95%CI) P value
Gender
Male (reference)
Female 2.70 (1.00, 7.27) 0.049
Primary Diagnosis
Others (reference)
Lymphoid malignancies & Aplastic
anemia
2.72 (0.99, 7.48) 0.053
Age at MR study
≥10 Years (reference)
≥10 Years 4.50 (1.16, 17.17) 0.030
1

Data from patients younger than 2 and patients who did not have height/weight measured at MR date were not included.

Abbreviations: BMI, body mass index percentile; MR, magnetic resonance;